Mortality from pneumonia and risk conditions during influenza epidemics. High influenza morbidity during nonepidemic

JAMA
|June 27, 1977
PubMed

Insights

Annual influenza vaccination may not be recommended for high-risk groups and older adults. Most severe influenza cases causing significant bed disability are not caused by influenza viruses.

Area of Science:

  • Epidemiology
  • Public Health
  • Virology

Background:

  • Recent influenza epidemics have not shown increased mortality from pneumonia or chronic diseases.
  • Excess mortality attributed to influenza as a primary cause of death averages only about 4,000 deaths per epidemic in the US.
  • Significant bed disability from clinical influenza occurs annually, not just during epidemics.

Purpose of the Study:

  • To evaluate the necessity of annual influenza vaccination for specific populations.
  • To assess the actual impact of influenza viruses on mortality and morbidity.

Main Methods:

  • Analysis of US mortality data during recent influenza epidemics.
  • Review of clinical influenza episode data, including bed disability days.
  • Assessment of the role of influenza viruses versus other causes of severe clinical influenza.

Main Results:

  • No significant increase in mortality from pneumonia and high-risk chronic diseases observed during recent influenza epidemics.
  • Average excess mortality directly attributed to influenza was approximately 4,000 deaths per epidemic.
  • Millions of clinical influenza episodes causing substantial bed disability occur annually, independent of influenza virus activity.

Conclusions:

  • The data does not support the routine annual administration of influenza vaccines to high-risk groups or individuals over 64.
  • Most severe clinical influenza cases are not caused by influenza viruses, questioning the efficacy of widespread vaccination strategies.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...